» Articles » PMID: 16442654

Total Amino Acid Stabilization During Cell-free Protein Synthesis Reactions

Overview
Journal J Biotechnol
Date 2006 Jan 31
PMID 16442654
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Limitations in amino acid supply have been recognized as a substantial problem in cell-free protein synthesis reactions. Although enzymatic inhibitors and fed-batch techniques have been beneficial, the most robust way to stabilize amino acids is to remove the responsible enzymatic activities by genetically modifying the source strain used for cell extract preparation. Previous work showed this was possible for arginine, serine, and tryptophan, but cysteine degradation remained a major limitation in obtaining high protein synthesis yields. Through radiolabel techniques, we confirmed that cysteine degradation was caused by the activity of glutamate-cysteine ligase (gene gshA) in the cell extract. Next, we created Escherichia coli strain KC6 that combines a gshA deletion with previously described deletions for arginine, serine, and tryptophan stabilization. Strain KC6 grows well, and active cell extract can be produced from it for cell-free protein synthesis reactions. The extract from strain KC6 maintains stable amino acid concentrations of all 20 amino acids in a 3-h batch reaction. Yields for three different proteins improved 75-250% relative to cell-free expression using the control extract.

Citing Articles

Cell-Free Gene Expression: Methods and Applications.

Hunt A, Rasor B, Seki K, Ekas H, Warfel K, Karim A Chem Rev. 2024; 125(1):91-149.

PMID: 39700225 PMC: 11719329. DOI: 10.1021/acs.chemrev.4c00116.


Streamlining the Detection of Human Thyroid Receptor Ligand Interactions with XL1-Blue Cell-Free Protein Synthesis and Beta-Galactosidase Fusion Protein Biosensors.

Hunt J, Free T, Galiardi J, Watt K, Wood D, Bundy B Life (Basel). 2023; 13(10).

PMID: 37895354 PMC: 10608756. DOI: 10.3390/life13101972.


An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics.

Borhani S, Levine M, Krumpe L, Wilson J, Henrich C, OKeefe B N Biotechnol. 2023; 76:13-22.

PMID: 37054948 PMC: 10330340. DOI: 10.1016/j.nbt.2023.04.003.


Investigating and Optimizing the Lysate-Based Expression of Nonribosomal Peptide Synthetases Using a Reporter System.

Dinglasan J, Sword T, Barker J, Doktycz M, Bailey C ACS Synth Biol. 2023; 12(5):1447-1460.

PMID: 37039644 PMC: 11236431. DOI: 10.1021/acssynbio.2c00658.


An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates.

Hanson J, Groff D, Carlos A, Usman H, Fong K, Yu A Bioengineering (Basel). 2023; 10(3).

PMID: 36978695 PMC: 10045668. DOI: 10.3390/bioengineering10030304.